Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D3PF
|
||||
Former ID |
DNC009569
|
||||
Drug Name |
VOROZOLE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Discontinued in Phase 2 | [545194] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H13ClN6
|
||||
Canonical SMILES |
CN1C2=C(C=CC(=C2)C(C3=CC=C(C=C3)Cl)N4C=NC=N4)N=N1
|
||||
InChI |
1S/C16H13ClN6/c1-22-15-8-12(4-7-14(15)20-21-22)16(23-10-18-9-19-23)11-2-5-13(17)6-3-11/h2-10,16H,1H3
|
||||
InChIKey |
XLMPPFTZALNBFS-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 118949-22-7
|
||||
PubChem Compound ID | |||||
SuperDrug ATC ID |
L02BG05
|
||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 19 | Target Info | Inhibitor | [529570] | |
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
Reactome | Endogenous sterols | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.